these data imply that , at present , a decision to prescribe postmenopausal hormones should be based primarily on weighing possible benefits from the relief of menopausal symptoms against unknown or suspected risks of other diseases , particularly uterine cancer in women with an intact uterus .
C0153567
uterine cancer
C0042149
uterus